NRXS — Neuraxis, INC

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 1933567 ·
Last close
$4.61
Market Cap
$65.43M
52W High
$9.33
52W Low
$2.21
ADV30
168,233
Next earnings
—
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 2,027,904 1,756,241 -6,578,923 -6,545,442 6,655,045 4,476,617 3,032,634
Jun 2026 1,928,695 1,656,122 -2,124,712 -2,085,746 9,996,160 8,322,258 3,261,107
Mar 2026 1,607,883 1,389,517 -1,740,679 -1,761,432 8,745,706 7,078,659 2,998,156
Dec 2025 968,127 826,476 -1,716,868 -1,708,657 6,404,036 4,965,072 3,004,664

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,461,803
Investing CF
$-125,965
Financing CF
$6,687,276
CapEx
$-144,950
Dividends Paid
$-18
Buybacks
—
EPS Diluted TTM
$-1.13
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-76,399,554
Inventory
$254,656
Receivables
$809,341
ST Investments
—
EBIT TTM
$-12,006,532
Pretax Income TTM
$-12,101,277
Interest Exp TTM
$94,745
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,316,119
EBITDA
$-7,609,116
Free Cash Flow
$-3,154,924
Enterprise Value
$70,321,384
Total Cash
$8,322,258
Total Debt
$279,392
Shares Out
14,193,209
Trailing EPS
$-1.08
Book Value
$0.32
ROE
-139.8%
ROA
-56.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 3,569,282 -7,829,908 -7,800,555 6,404,036 3,004,664 3,399,372 -6,432,843
Dec 2024 2,685,925 -7,156,817 -8,241,501 4,757,572 2,689,824 2,067,748 -6,098,264
Dec 2023 2,460,049 -6,664,495 -14,626,683 509,498 1,912,739 -1,403,241 -6,693,978
Dec 2022 2,684,735 -3,372,238 -4,780,061 1,480,644 7,054,257 -5,573,613 -2,298,004

TTM Snapshot

Revenues TTM
$5,316,119
NetIncome TTM
$-7,678,631
OpCashFlow TTM
—
Assets (Latest)
$9,996,160
Forward EPS
$-0.56

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $4.87 · call volume: 56 · put volume: 1

Peers — same industry

TickerNameMarket CapLastDaily %
NTRB NutriBand Inc. $67.95M $5.59 —
APT ALPHA PRO TECH LTD $68.25M $6.65 —
EBRCZ EBR Systems, Inc. $70.01M $0.08 —
QTEX QTREX Quantum Ltd. $60.72M $1.09 —
LNSR LENSAR, Inc. $60.36M $4.91 —

News headlines (Yahoo Finance, 1h cache)

Neuraxis Inc (NRXS) Q3 2026 Earnings Call Highlights: Record Revenue, 150% Growth, and ...
2026-11-09 23:03 · Yahoo
NeurAxis, Inc. Q3 2026 Earnings Call Summary
2026-11-09 21:49 · Yahoo
NeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue Growth
2026-11-09 12:05 · Yahoo
NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026
2026-10-27 11:00 · Yahoo
NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
2026-10-15 13:18 · Yahoo
NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
2026-09-29 11:00 · Yahoo
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
2026-09-16 13:00 · Yahoo
NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up
2026-08-14 15:42 · Yahoo
Neuraxis Inc (NRXS) (Q2 2026) Earnings Call Highlights: Revenue Surges 116% as Payer Coverage ...
2026-08-11 21:00 · Yahoo
NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth
2026-08-11 11:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.